AMV GmbH (production of finished dosage form, primary and secondary packaging, batch control, batch release)

The drug is used for the treatment of hormone-dependent advanced prostate cancer, as well as high-risk localized prostate cancer and locally advanced prostate cancer (in combination with radiation). It also helps to determine the hormonal sensitivity of the tumor.

Dosage form: implant

ATC: L02AE02